Back to top

Positive Report for Carmila SAS (CARM) from Jefferies

Jefferies analyst Pierre-Emmanuel Clouard upgraded Carmila SAS to a Buy today and set a price target of €20.00. According to TipRanks, Clouard is r...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Carisma Therapeutics Inc. (CARM)